Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle

G Giannaccare, M Pellegrini, F Bernabei… - Graefe's Archive for …, 2019 - Springer
Purpose Graft-versus-host disease (GVHD) is a major complication of allogeneic
hematopoietic stem cells transplantation, occurring in about half of transplanted patients …

[HTML][HTML] Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease

C Tappeiner, A Heiligenhaus, JP Halter… - Frontiers in …, 2023 - frontiersin.org
Graft-versus-host disease (GVHD) is characterized by tissue inflammation in the host
following an allogeneic hematopoietic cell transplantation (HCT). The pathophysiology is …

Incidence, risk factors and complications of ocular graft-versus-host disease following hematopoietic stem cell transplantation

M Pellegrini, F Bernabei, F Barbato, M Arpinati… - American journal of …, 2021 - Elsevier
Purpose The purpose of this research was to evaluate the incidence, risk factors, and
complications of ocular graft-versus-host disease (GVHD) in a large single-center study …

Long‐term follow‐up of hematopoietic stem cell transplant survivors: a focus on screening, monitoring, and therapeutics

IM Saunders, M Tan, D Koura… - … : The Journal of Human …, 2020 - Wiley Online Library
Annually,~ 50,000 patients undergo hematopoietic stem cell transplantation (HCT)
worldwide with almost 22,000 of these patients receiving HCT in the United States. HCT is a …

[HTML][HTML] Incidence of ocular manifestations in patients with graft versus host disease after allogeneic stem cell transplant in Riyadh, Saudi Arabia

T Aldebasi, R Bashir, S Gangadharan… - International Journal …, 2022 - ncbi.nlm.nih.gov
AIM To evaluate the incidence and severity of ocular graft versus host disease (oGVHD) in
patients who underwent allogeneic stem cell transplant (SCT) in King Abdul-Aziz Medical …

[HTML][HTML] International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update

SJ Rotz, NS Bhatt, BK Hamilton, C Duncan… - … and Cellular Therapy, 2024 - Elsevier
As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications
and international access improves, the number of HCTs performed annually continues to …

Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation

X Wang, Y Lu, H Li, Z Ma, J Hong, C Wang - Journal of Personalized …, 2023 - mdpi.com
Objective: To analyze and summarize the clinical and imaging characteristics of patients
with cytomegalovirus retinitis (CMVR) relapse after hematopoietic stem cell transplantation …

Maculopathy in sickle cell disease

I Bachmeier, C Blecha, J Föll, D Wolff, H Jägle - Der Ophthalmologe, 2021 - Springer
Zusammenfassung Hintergrund Die Sichelzellerkrankung (SZE) ist eine hereditäre
Hämoglobinopathie, die durch rezidivierende vasookklusive Episoden zur …

Assessing inpatient platelet ordering practice: evaluation of computer provider order entry overrides

KL O'Brien, Y Chen, L Uhl - Vox Sanguinis, 2021 - Wiley Online Library
Background and Objectives Judicious utilization of platelet products protects a limited
resource and mitigates risks of transfusion. At many institutions, computer physician order …

Long-Term Follow-Up of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation

JL Garcia, AV de Macedo, PRD Pelegrina… - Journal of Bone …, 2021 - jbmtct.com.br
Hematopoietic stem cell transplantation (HSCT) offers the opportunity for cure to patients
with malignant and non-malignant diseases. Given the myriad advances in the past few …